Label: PURIPATCH FOR ACNE TREATMENT- salicylic acid patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated August 13, 2020

If you are a consumer or patient please visit this version.

  • Active ingredients

    Niacinamide (2%)

    Allantoin (0.3%)

  • Purpose

    Skin protectant

  • Uses

    Moisturizes skin.

  • Warnings

    For external use only

    Do not use when skin is red, inflamed, irritated, or painful

    When using this product

    - do not apply on other parts of the body avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water

    - do not apply directly to wound or open cut

    Stop use and ask a doctor if

    - Rash or irritation on skin develops and lasts

  • Keep out of reach of children

    If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    1) After cleansing, wipe off water using a towel. 2) Open the package and take out the mask. 3) Place the mask around eyes first, and then the rest of face. 4) Relax with the mask on for 15-20 minutes, then remove the sheet. 5) Gently tap the remaining serum onto skin and let it absorb.

  • Inactive ingredients

    Water, Methylpropanediol, Glycerin, Hydrolyzed Egg Shell Membrane, Pearl Extract, Ethylhexylglycerin, Xylitylglucoside, Anhydroxylitol, xylitol, Glucose, Sodium Pca, Sodium Lactate, Hydroxyethyl Urea, Aspartic Acid, PCA, Glycine, Alanine, Serine, Valine, Dipotassium Glycyrrhizate, Proline, Threonine, Isoleucine, Histidine, Phenylalanine, Calcium Pantothenate, Sodium Ascorbyl Phosphate, Tocopheryl Acetate, Pyridoxine HCl, Maltodextrin, Sodium Starch Octenylsuccinate, Sodium Hyaluronate, Butylene Glycol, Hydrolyzed Jojoba Esters, Betaine, Carbomer, Ammonium Acryloyldimethyltaurate/Vp Copolymer, t-Butyl Alcohol, PEG-60 Hydrogenated Castor Oil, Hexyl Laurate, Caffeine, Sodium Acrylates Copolymer, Lecithin, PEG-2M, Silica, Arginine, Caprylic/Capric Triglyceride, Cellulose Gum, Hydroxyacetophenone, Hexylene Glycol, Caprylhydroxamic Acid, Propanediol, Ethyl Hexanediol, 1,2-Hexanediol, Chlorphenesin, Dehydroacetic Acid, Disodium EDTA, Fragrance

  • EMP COLLAGEN BOOST

    emp collagen boost

  • INGREDIENTS AND APPEARANCE
    PURIPATCH FOR ACNE TREATMENT 
    salicylic acid patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71727-106
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.6 g  in 100 mm
    Inactive Ingredients
    Ingredient NameStrength
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    KAOLIN (UNII: 24H4NWX5CO)  
    LIMONENE, (+)- (UNII: GFD7C86Q1W)  
    MELALEUCA ALTERNIFOLIA LEAF (UNII: G43C57162K)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    LINALOOL, (-)- (UNII: 3U21E3V8I2)  
    WATER (UNII: 059QF0KO0R)  
    ACRYLIC ACID/DIMETHICONE METHACRYLATE/ETHYLHEXYL ACRYLATE COPOLYMER (UNII: E5024Y9FFQ)  
    EPILOBIUM ANGUSTIFOLIUM WHOLE (UNII: C278QS9YBT)  
    SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
    C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
    PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER (UNII: 788QAG3W8A)  
    NONOXYNOL-30 (UNII: JJX07DG188)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    VITIS VINIFERA SEED (UNII: C34U15ICXA)  
    LAURETH-7 (UNII: Z95S6G8201)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71727-106-0272 in 1 BOX08/13/2020
    1NDC:71727-106-0112.25 mm in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D08/13/2020
    Labeler - iMode Korea, Inc. (694627846)
    Registrant - iMode Korea, Inc. (694627846)
    Establishment
    NameAddressID/FEIBusiness Operations
    Kovas Co., Ltd.688783559manufacture(71727-106)